Skip to main content

UCB to acquire Ra Pharmaceuticals in $2.1 billion deal

Shareholders of Ra Pharma will receive $48 for each share held, a joint statement by the two companies said Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.